Cambridge Investment Research Advisors
JUNO

Cambridge Investment Research Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,564
Closed -$209K – 2286
2017
Q4 		$209K Buy
+4,564
New +$228K ﹤0.01% 1899

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Cambridge Investment Research Advisors's JUNO Position: Q1 2018 in Review

Cambridge Investment Research Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 4,564 shares — an estimated $209K sold.

Cambridge Investment Research Advisors first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $209K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Cambridge Investment Research Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 4,564 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $209K.
  • Cambridge Investment Research Advisors first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Juno Therapeutics, Inc. position peaked at $209K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.